Addressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
Cathleen Dohrn, PhD
Advertisement
Articles by Cathleen Dohrn, PhD
Cathleen Dohrn, Senior Scientific Director for Continuum Clinical, describes the momentous challenges in clinical trials presented by low awareness of nonalcoholic steatohepatitis.
A sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.
Advertisement
Latest Updated Articles
- Considering Sex as a Variable in Clinical Trials
Published: January 23rd 2018 | Updated:
- Low Awareness of NASH Presents Significant Clinical Trial Challenges
Published: June 17th 2019 | Updated:
Challenges Emerge from Low NASH AwarenessPublished: July 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
dashClinical: Real-Time Participant Payments
4
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
